Importantly, the high sensitivity, specificity, and AUC in BRAF-MUT advanced melanoma samples suggested that PLA1A could be used as a marker for an effective prediction of advanced BRAF-mutant melanoma cancer. This evidence concerns the gene PLA1A and cancer.